Back to search
Pediatric Patients With Cancer
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Pediatric Patients With Cancer trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Pediatric Patients With Cancer trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
Background: Chimeric antigen receptor T-cell (CART) therapy is a form of immunotherapy which can be used to treat people with relapsed B-ALL. For those who ach…
Cancer-related fatigue is a common and debilitating late effect in pediatric brain tumor survivors. Currently, evidence-based recommendations to ameliorate this…
This study will evaluate the safety of tisagenlecleucel that is out of specification( OOS) for release as commercial product. Specifically, this study will eval…
The purpose of this study is to evaluate the safety and pharmacokinetics of eflapegrastim in pediatric participants with solid tumors or lymphoma and treated wi…
Background: Approximately 150 cases of cancer per one million per year are considered rare cancers. While all tumors originate from genetic changes, a small pe…
The main purpose of this study in participants with PIK3CA-mutated LyM is to assess the change in radiological response and symptom severity upon treatment with…
The goal of this study is to learn if an online computerized training program improves processing speed in children with pediatric brain tumors. The main questi…
A roll-over study to assess long-term effect in pediatric patients treated with dabrafenib and/or trametinib.